Pfizer Follows $10bn Metsera Purchase By Licensing YaoPharma Obesity Asset

 
• By Joseph Haas
  
Pfizer
Pfizer continues building its obesity portfolio via licensing deal with YaoPharma • Source: Shutterstock

More from Deals

More from Business